| Literature DB >> 18837991 |
M H Karavolos1, H Spencer, D M Bulmer, A Thompson, K Winzer, P Williams, J C D Hinton, C M Anjam Khan.
Abstract
BACKGROUND: The successful interaction of bacterial pathogens with host tissues requires the sensing of specific chemical and physical cues. The human gut contains a huge number of neurons involved in the secretion and sensing of a class of neuroendocrine hormones called catecholamines. Recently, in Escherichia coli O157:H7, the catecholamines adrenaline and noradrenaline were shown to act synergistically with a bacterial quorum sensing molecule, autoinducer 3 (AI-3), to affect bacterial virulence and motility. We wished to investigate the impact of adrenaline on the biology of Salmonella spp.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18837991 PMCID: PMC2576261 DOI: 10.1186/1471-2164-9-458
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Strains plasmids and primers used in this study
| Strains | ||
| Name | ||
| Parent strain | [ | |
| SL1344 Δ | This work | |
| SL1344 Δ | This work | |
| SL1344 Δ | This work | |
| SL1344 Δ | This work | |
| SL1344 (pMK1 | This work | |
| SL1344 (pMK1 | This work | |
| Plasmids | ||
| Name | ||
| Cloning vector | [ | |
| [ | ||
| pBR322 with | This work | |
| pMK1 | This work | |
| pMK1 | This work | |
| Primers | ||
| Name | ||
| GCG | cloning | |
| GCG | cloning | |
| CGC | cloning | |
| CGC | cloning | |
| ATGTCGGACTTTTTGCCTTTC | qPCR | |
| ATATTGATTGCCAGTTAGCC | qPCR | |
| ATGAGTTATACACTGCCATC | qPCR | |
| GCAAACTCAGGCAGGTTTTC | qPCR | |
| ATGGCGCGTCTTAAAACTGC | qPCR | |
| GCGGCAGGCGCTGCGGTTAC | qPCR | |
| ATGTCATTTTCTGAAAGCCG | qPCR | |
| AATGCCAGTAATTTGCTGAG | qPCR | |
| ATGCGTATACCTTTCACCCG | qPCR | |
| CTGAATGCGCGCTCGCCTTC | qPCR | |
| CGCACGGTTCGCGGGTTTGG | λ-red | |
| GTAGTGTGCTGATTGTCAGC | λ-red | |
| CTACATGCTGGTTGCCACTGAGGAAAGCTAAGTGAGCCTGGTGTAGGCTGGAGCTGCTTC | λ-red | |
| AGTTTTATCTATGTGTGGGTCACGACGTATTAAACGCCTGATTCCGGGGATCCGTCGACC | λ-red | |
| AGTGCAATTTCTGTCACTTC | λ-red | |
| CAGGAAAGAGGAGGATATAA | λ-red | |
| TCTAATGAAGTGAATCGTTTAGCAACAGGACAGATTCCGCGTGTAGGCTGGAGCTGCTTC | λ-red | |
| AAAAGCCAACCGGGCGGTTGGCTCTTCGAAAGATTTACACATTCCGGGGATCCGTCGACC | λ-red | |
| TAATCGTTCATTGCTATGCT | λ-red | |
| AACACCACCTTTAACTACCC | λ-red | |
| ACCTATCGCCATGAACTATCGTGGCGACGGAGGATGAATAGTGTAGGCTGGAGCTGCTTC | λ-red | |
| TCGGGTTGCGGCGTTGAACGGCTTAAACCGCCTGTTTTAAATTCCGGGGATCCGTCGACC | λ-red | |
Restriction endonuclease sites are in bold.
Adrenaline regulated genes of S. Typhimurium
| STM0192, | ATP-binding component of hydroxymate-dependent iron transport | ||
| STM3159, | uptake of enterochelin; | ||
| STM0191, | outer membrane protein receptor for ferrichrome | ||
| STM3158, | uptake of enterochelin; | ||
| STM0596, | 2,3-dihydroxybenzoate-AMP ligase | ||
| STM3506, | ferrous iron transport protein B | ||
| STM3505, | ferrous iron transport protein A | ||
| STM2861, | |||
| STM2862, | |||
| STM4055, | superoxide dismutase | ||
| STM1728, | putative cytoplasmic protein | ||
| STM2263, | putative ABC-type multidrug/protein/lipid transport system | ||
| STM1586 | putative periplasmic protein, similar to | ||
| STM1729, | putative cytoplasmic protein | ||
| STM2299, | transformylase | ||
| STM1935, | cytoplasmic ferritin | ||
| STM2297, | 4-amino-4-deoxy-L-arabinose LPS-modifying enzyme | ||
| STM2298, | glycosyl transferase | ||
| STM1176, | flagellar hook capping protein | ||
| STM2899, | invasion protein | ||
| STM2301, | polymyxin B resistance | ||
| STM3216 | putative methyl-accepting chemotaxis protein II, aspartate sensor receptor | ||
| STM1936, | putative cytoplasmic protein | ||
| STM4293, | putative integral membrane protein | ||
| STM2300, | cytoplasmic protein | ||
| STM0191, | outer membrane protein receptor for ferrichrome | ||
| STM0596, | 2,3-dihydroxybenzoate-AMP ligase | ||
| STM4055, | superoxide dismutase | ||
| STM2297, | 4-amino-4-deoxy-L-arabinose LPS-modifying enzyme | ||
| STM2899, | invasion protein | ||
Figure 1The . Pie chart displaying number of genes in selected categories significantly altered upon addition of adrenaline (50 μM). A detailed list of the genes can be found in Table 2.
Figure 2Diagrammatic representation of major operons affected by adrenaline. Chromosomal organisation of genes showing a significant transcriptional change upon addition of adrenaline (50 μM). Respective fold change values in relation to the untreated control are displayed within the individual gene. Unaffected genes within an operon are represented by skewed lines.
Figure 3Adrenaline affects expression of . A luminescent reporter fusion system (pMK1lux-P) was used to assess expression of the sodA gene during exposure to adrenaline. Exposure of SL1344pA to adrenaline (50 μM) for 30 minutes resulted in a significant (10%) increase in sodA expression (P ≤ 0.05). Addition of β-adrenergic blocker propranolol (500 μM) did not reverse the effect of adrenaline. Luminescence is expressed as a percentage of the water addition control in relative light units per culture optical density (RLU/OD600). Experiments were repeated at least three times. Asterisk indicates significant difference by the student t-test. Standard error bars are shown. Water, H2O; Adrenaline, ADR; Propranolol, PO.
Figure 4OxyR and manganese are necessary for survival upon exposure to adrenaline. The role of the major oxidative stress regulator OxyR in the ability of Salmonella spp. to survive exposure to various adrenaline concentrations was assessed. (A) Deletion of oxyR in SL1344oxyR results in a dramatic loss of viability when exposed to adrenaline (50 μM) for 30 minutes. The effect of adrenaline is significantly lessened by addition of propranolol (PO) at 500 μM. Addition of the adrenaline derivative metanephrine (50 μM) which cannot bind iron has no significant effect on cell viability. Addition of manganese (5 mM) also fully counteracts the growth inhibition observed by adrenaline while the metal by itself (Mn) does not affect survival. SL1344 viability is unaffected by adrenaline (data not shown). (B) Measurement of total cell iron indicating a significant 4-fold increase upon exposure of SL1344 to adrenaline, reduced levels upon simultaneous exposure to propranolol and adrenaline, and also significantly elevated levels in SL1344oxyR. (C) Measurement of total cell manganese indicating significantly reduced (3-fold) levels in SL1344oxyR and slightly reduced levels in SL1344 upon addition of adrenaline or simultaneous exposure to propranolol and adrenaline. Experiments were repeated at least three times. Asterisk indicates significant difference by the student t-test. Standard error bars are shown. Adrenaline, ADR; Propranolol, PO; Metanephrine, MNPH; Manganese, Mn.
Figure 5Expression of the . Expression of the pmrHFIJKLM operon after a 30 minute exposure to adrenaline (50 μM) was assessed in SL1344pM by measuring luminescence per OD600 as described in "Methods". The significant transcriptional reduction (10%; P ≤ 0.05) in expression was fully reversed by addition of β-adrenergic blocker propranolol (500 μM). Luminescence is expressed as a percentage of the water addition control in relative light units per culture optical density (RLU/OD600). Experiments were repeated at least three times. Asterisk indicates significant difference by the student t-test. Standard error bars are shown. Water, H2O; Adrenaline, ADR; Propranolol, PO.
Figure 6Adrenaline modulates the ability of . We tested the effect of pre-exposure to adrenaline on the ability of Salmonella to resist the antimicrobial peptide polymyxin B. Addition of adrenaline (50 μM) significantly reduced Salmonella survival during exposure to polymyxin B (0.15 μg ml-1). This was fully reversed by the β-adrenergic blocker propranolol (500 μM). Sensitivity levels of the basS mutant (SL1344basS) to polymyxin B were very similar to those of the adrenaline-treated SL1344. Reversal of polymyxin B sensitivity by propranolol is dependent on the presence of basS. Experiments were repeated at least three times. Asterisk indicates significant difference by the student t-test. Standard error bars are shown. Water, H2O; Adrenaline, ADR; Polymyxin B, PB; Propranolol, PO.